Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosin-kinase inhibitors: a real-world analysis
| Autor: | Stefanini, B., Bucci, L., Santi, V., Reggidori, N., Rampoldi, D., Lani, L., Trevisani, F. |
|---|---|
| Zdroj: | In Digestive and Liver Disease March 2022 54 Supplement 1:S3-S3 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect